Scientists developed a DNA or gene test that can differentiate between patients who are likely to benefit from the treatment ...

Millions of people with breast cancer could safely avoid chemotherapy as scientists have developed a groundbreaking DNA test.

Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large ...

Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large ...

Women with breast cancer could be spared chemotherapy thanks to a new genetic test. A breakthrough trial has found that women ...

A new DNA test could help screen whether patients require the treatment or not, according to a new international trial.

Millions of breast cancer patients could be spared chemotherapy with a revolutionary new genomic test, a clinical trial has shown. The most common type of cancer in women in the UK, breast cancer is ...

Prosigna identified a large high-clinical-risk subgroup with minimal chemotherapy benefit, estimated to avert at most two recurrences per 100 patients treated. Enrollment broadened prior assay use by ...

A groundbreaking international trial, Optima, reveals a genomic test, Prosigna, can identify breast cancer patients unlikely ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...